Valuing the benefit of diagnostic testing for genetic causes of idiopathic developmental disability: Willingness to pay from families of affected children

Clinical Genetics

Volumn 75, Issue 6, 2009, Pages 514-521

  Regier, Dean A ^a   Friedman, J M ^b   Makela, N ^b   Ryan, M ^c   Marra, C A ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Array genomic hybridization; Discrete choice experiment; Genetic testing; Willingness to pay

Indexed keywords

ADULT; ARRAY GENOMIC HYBRIDIZATION; ARTICLE; ATTITUDE TO HEALTH; CASE REPORT; CHROMOSOME ABERRATION; CONTROLLED STUDY; COST BENEFIT ANALYSIS; CYTOGENETICS; DEVELOPMENTAL DISORDER; DIAGNOSTIC VALUE; DNA HYBRIDIZATION; FEMALE; GENETIC SCREENING; HEALTH CARE; HUMAN; IDIOPATHIC DEVELOPMENTAL DISABILITY; INTERMETHOD COMPARISON; MALE; PRIORITY JOURNAL; SOCIAL WELFARE; SOCIOECONOMICS;

ADULT; ATTITUDE TO HEALTH; CANADA; CHILD; COMPARATIVE GENOMIC HYBRIDIZATION; DEVELOPMENTAL DISABILITIES; FAMILY; FEMALE; FINANCING, PERSONAL; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES; SOCIOECONOMIC FACTORS;

EID: 66549119634     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2009.01193.x     Document Type: Article

References (33)

1. Crow YJ, Tolmie JL. Recurrence risks in mental retardation. J Med Genet 1998: 35: 177-182.
2. Shevell M, Ashwal S, Donley D et al. Practice parameter: Evaluation of the child with global developmental delay: Report of the Quality Standards Subcommittee of the American Academy of Neurology and The Practice Committee of the Child Neurology Society. Neurology 2003: 60: 367-380.
3. Roeleveld N, Zielhuis GA, Gabreels F. The prevalence of mental retardation: A critical review of recent literature. Dev Med Child Neurol 1997: 39: 125-132.
4. Rosenthal ET, Biesecker LG, Biesecker BB. Parental attitudes toward a diagnosis in children with unidentified multiple congenital anomaly syndromes. Am J Med Genet 2001: 103: 106-114.
5. Rauch A, Hoyer J, Guth S et al. Diagnostic yield of various genetic approaches in patients with unexplained developmental delay or mental retardation. Am J Med Genet A 2006: 140: 2063-2074.
6. Lenhard W, Breitenbach E, Ebert H et al. Psychological benefit of diagnostic certainty for mothers of children with disabilities: Lessons from Down syndrome. Am J Med Genet 2005: 133: 170-175.
7. van Karnebeek CD, Jansweijer MC, Leenders AG et al. Diagnostic investigations in individuals with mental retardation: A systematic literature review of their usefulness. Eur J Hum Genet 2005: 13: 6-25.
8. Moeschler JB, Shevell M, Genetics C. Clinical genetic evaluation of the child with mental retardation or developmental delays. Pediatrics 2006: 117: 2304-2316.
9. van Karnebeek CD, Scheper FY, Abeling NG et al. Etiology of mental retardation in children referred to a tertiary care center: A prospective study. Am J Ment Retard 2005: 110: 253-267.
10. Zahir F, Friedman JM. The impact of array genomic hybridization on mental retardation research: A review of current technologies and their clinical utility. Clin Genet 2007: 72: 271-287.
11. Subramonia-Iyer S, Sanderson S, Sagoo G et al. Array-based comparative genomic hybridization for investigating chromosomal abnormalities in patients with learning disability: Systematic review meta-analysis of diagnostic and false-positive yields. Genet Med 2007: 9: 74-79.
12. Ryan M, Gerard K, Amaya-Amaya M. Using discrete choice experiments to value health and health care. Dordrecht: Springer, 2007.
13. Bishop AJ, Marteau TM, Armstrong D et al. Women and health care professionals'preferences for Down's Syndrome screening tests: A conjoint analysis study. BJOG 2004: 111: 775-779.
14. Lewis SM, Cullinane FM, Carlin JB et al. Women's and health professionals' preferences for prenatal testing for Down syndrome in Australia. Aust N Z J Obstet Gynaecol 2006: 46: 205-211.
15. Ryan M, Diack J, Watson V et al. Rapid prenatal diagnostic testing for Down syndrome only or longer wait for full karyotype: The views of pregnant women. Prenat Diagn 2005: 25: 1206-1211.
16. Ryan M, Skatun D. Modelling non-demanders in choice experiments. Health Econ 2004: 13: 397-402.
17. Hensher D, Rose J, Greene WH Applied choice analysis: A primer Cambridge: Cambridge University Press, 2005.
18. Sandor Z, Wedel M. Heterogeneous conjoint choice designs. J Mark Res 2005: 42: 210-218.
19. Train KE, Sonnier G. Mixed logit with bounded distributions of correlated partworths. In: Alberini A, Scarpa R, eds. Applications of simulation methods in environmental and resource economics Vol. 1. Dordrecht: Springer, 2005: 117-134.
20. Train KE. Discrete choice methods with simulation. New York: Cambridge University Press, 2003.
21. Leiter V. "Nobody's just normal, you know": The social creation of developmental disability. Soc Sci Med 2007: 65: 1630-1641.
22. Ryan M. Deriving welfare measures in discrete choice experiments: A comment to Lancsar and Savage (1). Health Econ 2004: 13: 909-912.
23. Lancsar E, Savage E. Deriving welfare measures from discrete choice experiments: Inconsistency between current methods and random utility and welfare theory. Health Econ 2004: 13: 901-907.
24. Small KA, Rosen HS. Applied welfare economics with discrete choice models. Econometrica 1981: 49: 105-130.
25. de Vries BB, Pfundt R, Leisink M et al. Diagnostic genome profiling in mental retardation. Am J Hum Genet 2005: 77: 606-616.
26. Friedman JM, Baross A, Delaney AD et al. Oligonucleotide microarray analysis of genomic imbalance in children with mental retardation. Am J Hum Genet 2006: 79: 500-513.
27. Menten B, Maas N, Thienpont B et al. Emerging patterns of cryptic chromosomal imbalance in patients with idiopathic mental retardation and multiple congenital anomalies: A new series of 140 patients and review of published reports. J Med Genet 2006: 43: 625-633.
28. Fan YS, Jayakar P, Zhu H et al. Detection of pathogenic gene copy number variations in patients with mental retardation by genomewide oligonucleotide array comparative genomic hybridization. Hum Mutat 2007: 28: 1124-1132.
29. Hoyer J, Dreweke A, Becker C et al. Molecular karyotyping in patients with mental retardation using 100K single-nucleotide polymorphism arrays. J Med Genet 2007: 44: 629-636.
30. Borghi J. Aggregation rules for cost-benefit analysis: A health economics perspective. Health Econ 2008: 17(7): 863-875.
31. Gillman M, Heyman B, Swain J. What's in a name? The implications of diagnosis for people with learning difficulties and their family carers. Disabil Soc 2000: 15: 389-409.
32. Drummond M, O'Brien B, Stoddart G et al. Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press 1997.
33. Telser H, Zweifel P. Validity of discrete choice experiments evidence for health risk reduction. Appl Econ 2007: 39: 69-78.